Anti-mineralocorticoid agent reduced albuminuria, but not eGFR-based kidney outcome
Fewer cancers, cancer deaths prevented; higher cost per quality-year saved
Researchers observed dose-response relationship for increasing BMI and long COVID risk
Meta-analysis says anti-inflammatory relievers beat bronchodilators in reducing exacerbations
Where medicine is all fun and games
You passed medical training, now see if you can pass our weekly quiz
Multi-step, condition-based, and doctor-reviewed resource library for physicians and their patients.See All Medical Journeys >
Chunks of text or even entire sentences were made up, according to experts
What to know about "falling back"
Larger pool of TAVR candidates suggested by EARLY TAVR trial results
Associations observed when kids were 5 years old
Health news and commentary gathered by 乌鸦传媒 staff
Surrogate endpoint of urinary protein-to-creatinine ratio "widely considered to be predictive"
Significant reduction in hives and itch in antihistamine-resistant patients
Small pharmacies face deep financial disparities
Treatment with iptacopan reduces proteinuria in interim APPLAUSE-IgAN analysis
Study also raises question of antibiotic prophylaxis in kids with common congenital anomaly
Also in TTHealthWatch: best medications for opioid use disorder
An excerpt from Williams' book, The Bodies Keep Coming
Median OS as high as 43 months with mutation-guided targeted agents plus immunotherapy
Nearly two dozen people have been hospitalized
EASI-75 was achieved by majority of patients taking 15 mg or 30 mg at 76 weeks
Easy to apply, uses parameters commonly measured in outpatient and inpatient settings
Three physicians face crossroads in patient care
乌鸦传媒 reporters offer further insights into these recently covered topics
Also in TTHealthWatch: menopause hormone therapy in the U.S.
A discussion with the former CEO of the Bill & Melinda Gates Foundation
'I just had this reverence for the court. I don't anymore,' says Lawrence Gostin, JD
An examination of what's driving sexual violence against women in medicine
This newly approved testing modality brings challenges and opportunities
Unequal access threatens to worsen disparities
The potential benefits of CAR T-cell therapies still far outweigh the risks